Prognose des europäischen Marktes für Schnelltests bis 2030 – Regionale Analyse – nach Typ (Schnelltests für Antigene, Schnelltests für Antikörper und andere), Produkt (rezeptfreie Schnelltests und professionelle Schnelltests), Technologie (Lateralflusstest, Festphasentest, Agglutination, Immunospot-Test und auf zellulären Komponenten basierend), Anwendung (Blutzuckertests, Tests auf Infektionskrankheiten, Schwangerschaft und Fruchtbarkeit, kardiometabolische Tests und andere) und Endbenutzer (Krankenhäuser und Kliniken, häusliche Pflege, Diagnosezentren und andere)
Strategische Initiativen der Hersteller treiben den europäischen Markt für Schnelltestkits an
Hersteller auf dem Markt für Schnelltestkits legen Wert auf die Einführung von Strategien wie Innovationen sowie Produkteinführungen und -zulassungen, um einen Wettbewerbsvorteil auf dem Markt zu erhalten. Solche strategischen Initiativen von Unternehmen auf dem Markt für Schnelltestkits kommen dem Gesamtmarkt zugute.
Im Jahr 2022 erhielt der in Singapur ansässige Diagnostikhersteller INEX Innovate, ein Pionier im Bereich der Frauen- und Fetalgesundheit in Asien, eine CE-Kennzeichnung für OvaCis Rapid Test, seine Vorzeigelösung für Eierstockkrebs. Bis Ende 2022 soll OvaCis – der erste Point-of-Care-Test (POCT) seiner Art, der im Operationssaal gutartige von bösartigen Eierstockzysten unterscheidet – auf dem EU- und südostasiatischen Markt debütieren.
Im Januar 2022 brachte OraSure Technologies, Inc., ein weltweit führendes Unternehmen für Point-of-Care- und Heimdiagnostiktests sowie Probenentnahmetechnologien, den OraQuick HIV-Selbsttest auf den europäischen Markt, einen oralen Abstrich-basierten Heimtest für HIV-1 und HIV-2. Der Test ist in sechs europäischen Ländern erhältlich: Großbritannien, Frankreich, Deutschland, Italien, Spanien und Portugal.
Im Jahr 2021 wurde FUJIFILM Europe GmbH nach Erteilung des CE-Zertifikats ermächtigt, das CE-Zeichen anzubringen und ein Antigentestkit zur Diagnose einer SARS-CoV-2-Infektion einzuführen. Die von Fujifilm verwendete Technik heißt proprietäre Silberamplifikations-Immunchromatographie und basiert auf derselben Technologie, die zur Verstärkung der zu entwickelnden Fotos verwendet wird.
Im Dezember 2020 erteilte die US-amerikanische Food and Drug Administration (FDA) eine Notfallzulassung (EUA) für einen virtuell geführten Schnelltest mit der BinaxNOW COVID-19 Ag Card (von Abbott), der zur Verwendung zu Hause zum Nachweis von COVID-19 vorgesehen ist. BinaxNOW ist ein weit verbreiteter und einer der günstigsten Schnelltests, der innerhalb von Minuten Ergebnisse liefert.
Im Juli 2020 erteilte die FDA eine Notfallzulassung (EUA) für einen schnellen SARS-CoV-2-Diagnosetest am Behandlungsort zur Verwendung mit ihrem weit verbreiteten BD Veritor Plus System. Der neue Test liefert Ergebnisse in 15 Minuten auf einem einfach zu verwendenden, tragbaren Gerät. Der Test sollte den Zugang zur COVID-19-Diagnostik verbessern, indem er Echtzeitergebnisse liefert und schnelle Entscheidungen ermöglicht, während sich der Patient noch in der Testeinrichtung befindet.
Marktübersicht für Schnelltestkits in Europa
Die Prävalenz von Diabetes in Deutschland hat stark zugenommen. Laut der International Diabetes Federation litten im Jahr 2021 etwa 62 Millionen Menschen an Diabetes. Darüber hinaus wurden laut dem Bericht des Europäischen Zentrums für die Prävention und Kontrolle von Krankheiten im Jahr 2019 in der Europäischen Union (EU) 8.641 Malariafälle registriert, von denen 8.638 (> 99 %) bestätigte Diagnosen waren. Im September 2022 unterzeichnete Deutschland ein Abkommen im Wert von 1,34 Milliarden US-Dollar mit dem Gemeinsamen Programm der Vereinten Nationen für HIV/AIDS (UNAIDS) zur Bekämpfung von AIDS, Tuberkulose und Malaria. damit erhöhte das Land seinen Beitrag um 30 % im Vergleich zu 2019. Darüber hinaus stellten internationale Quellen laut dem Bericht 2020 von endmalaria.org 69 % der Gesamtfinanzierung für die Bekämpfung und Ausrottung der Malaria bereit. Die Gesamtfinanzierung für die Bekämpfung und Ausrottung der Malaria belief sich auf 3,3 Milliarden US-Dollar, darunter 0,2 Milliarden US-Dollar aus Deutschland. Daher wird der Markt für Schnelltestkits in Deutschland in den kommenden Jahren voraussichtlich wachsen, da Infektionskrankheiten wie Diabetes, AIDS, Tuberkulose und Malaria zunehmend auftreten.
Umsatz und Prognose des europäischen Marktes für Schnelltestkits bis 2030 (in Millionen US-Dollar)
Segmentierung des europäischen Marktes für Schnelltestkits
Der europäische Markt für Schnelltestkits ist nach Typ, Produkt, Technologie, Anwendung, Endbenutzer und Land segmentiert. Nach Typ ist der europäische Markt für Schnelltestkits in Schnelltests auf Antigene, Schnelltests auf Antikörper und andere unterteilt. Das Segment der schnellen Antigentests hatte 2022 den größten Marktanteil.
In Bezug auf das Produkt ist der europäische Markt für Schnelltestkits in rezeptfreie Schnelltestkits und professionelle Schnelltestkits unterteilt. Das Segment der rezeptfreien Schnelltestkits hatte 2022 einen größeren Marktanteil.
Nach Technologie ist der europäische Markt für Schnelltestkits in Lateral-Flow-Assay, Festphasen-, Agglutinations-, Immunospot-Assay und zelluläre Komponenten-basierte Tests unterteilt. Das Segment der Lateral-Flow-Assays hatte 2022 den größten Marktanteil.
Basierend auf der Anwendung ist der europäische Markt für Schnelltestkits in Blutzuckertests, Tests auf Infektionskrankheiten, Schwangerschaft und Fruchtbarkeit, kardiometabolische Tests und andere unterteilt. Das Segment der Blutzuckertests hatte 2022 den größten Marktanteil.
In Bezug auf den Endverbraucher ist der europäische Markt für Schnelltestkits in Krankenhäuser und Kliniken, häusliche Pflege, Diagnosezentren und andere unterteilt. Das Segment Krankenhäuser und Kliniken hatte 2022 den größten Marktanteil.
Nach Ländern ist der europäische Markt für Schnelltestkits in Großbritannien, Deutschland, Frankreich, Italien, Spanien und das übrige Europa unterteilt. Deutschland dominierte 2022 den europäischen Marktanteil für Schnelltestkits.
F. Hoffmann-La Roche Ltd, Becton Dickinson and Co, ARKRAY Inc, Sysmex Partec GmbH, Fujirebio Europe NV, bioMerieux SA, Cepheid, Meril Life Sciences Pvt Ltd, QIAGEN NV, OraSure Technologies Inc, Guangzhou Wondfo Biotech Co Ltd, Denka Co Ltd, Abbott Laboratories, Trinity Biotech Plc, Premier Medical Corp Pvt Ltd, Bio-Rad Laboratories Inc, Hologic Inc, DiaSorin SpA und Beckman Coulter Inc sind einige der führenden Akteure auf dem europäischen Markt für Schnelltestkits.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Rapid Test Kits Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 Rising Prevalence of Genetic and Infectious Diseases
4.1.2 Strategic Initiatives by Manufacturers
4.2 Market Restraints
4.2.1 Uncertainties Related to Accuracy of Results
4.3 Market Opportunities
4.3.1 Increasing Preference for PCR Techniques
4.4 Future Trends
4.4.1 Innovations in Rapid Antigen Tests
4.5 Impact Analysis
5. Rapid Test Kits Market - Europe Market Analysis
5.1 Overview
5.2 Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030
6. Europe Rapid Test Kits Market Analysis - by Type
6.1 Overview
6.2 Rapid Antigen Testing
6.2.1 Overview
6.2.2 Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Rapid Antibody Testing
6.3.1 Overview
6.3.2 Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
7. Europe Rapid Test Kits Market Analysis - by Product
7.1 Overview
7.2 Over-the-Counter Rapid Testing Kit
7.2.1 Overview
7.2.2 Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Professional Rapid Testing Kit
7.3.1 Overview
7.3.2 Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8. Europe Rapid Test Kits Market Analysis - by Technology
8.1 Overview
8.2 Lateral Flow Assay
8.2.1 Overview
8.2.2 Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Solid Phase
8.3.1 Overview
8.3.2 Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Agglutination
8.4.1 Overview
8.4.2 Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Immunospot Assay
8.5.1 Overview
8.5.2 Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Cellular-Component Based
8.6.1 Overview
8.6.2 Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9. Europe Rapid Test Kits Market Analysis - by Application
9.1 Overview
9.2 Blood Glucose Testing
9.2.1 Overview
9.2.2 Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Infectious Disease Testing
9.3.1 Overview
9.3.2 Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.3.3 Infectious Disease Testing: Rapid Test Kits Market, by Application - Revenue and Forecast to 2030 (US$ Million)
9.4 Cardiometabolic Testing
9.4.1 Overview
9.4.2 Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Pregnancy and Fertility
9.5.1 Overview
9.5.2 Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10. Europe Rapid Test Kits Market Analysis - by End User
10.1 Overview
10.2 Hospital and Clinics
10.2.1 Overview
10.2.2 Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10.3 Diagnostic Centers
10.3.1 Overview
10.3.2 Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Home-Care
10.4.1 Overview
10.4.2 Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11. Europe Rapid Test Kits Market - Country Analysis
11.1 Europe
11.1.1 Europe: Rapid Test Kits Market - Revenue and Forecast Analysis - by Country
11.1.1.1 Germany
11.1.1.1.1 Overview
11.1.1.2 Germany: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.2.1 Germany: Rapid Test Kits Market Breakdown, by Type
11.1.1.2.2 Germany: Rapid Test Kits Market Breakdown, by Product
11.1.1.2.3 Germany: Rapid Test Kits Market Breakdown, by Technology
11.1.1.2.4 Germany: Rapid Test Kits Market Breakdown, by Application
11.1.1.2.4.1 Germany: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.2.5 Germany: Rapid Test Kits Market Breakdown, by End User
11.1.1.3 United Kingdom
11.1.1.3.1 Overview
11.1.1.4 United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.4.1 United Kingdom: Rapid Test Kits Market Breakdown, by Type
11.1.1.4.2 United Kingdom: Rapid Test Kits Market Breakdown, by Product
11.1.1.4.3 United Kingdom: Rapid Test Kits Market Breakdown, by Technology
11.1.1.4.4 United Kingdom: Rapid Test Kits Market Breakdown, by Application
11.1.1.4.4.1 United Kingdom: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.4.5 United Kingdom: Rapid Test Kits Market Breakdown, by End User
11.1.1.5 France
11.1.1.5.1 Overview
11.1.1.6 France: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.6.1 France: Rapid Test Kits Market Breakdown, by Type
11.1.1.6.2 France: Rapid Test Kits Market Breakdown, by Product
11.1.1.6.3 France: Rapid Test Kits Market Breakdown, by Technology
11.1.1.6.4 France: Rapid Test Kits Market Breakdown, by Application
11.1.1.6.4.1 France: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.6.5 France: Rapid Test Kits Market Breakdown, by End User
11.1.1.7 Italy
11.1.1.7.1 Overview
11.1.1.8 Italy: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.8.1 Italy: Rapid Test Kits Market Breakdown, by Type
11.1.1.8.2 Italy: Rapid Test Kits Market Breakdown, by Product
11.1.1.8.3 Italy: Rapid Test Kits Market Breakdown, by Technology
11.1.1.8.4 Italy: Rapid Test Kits Market Breakdown, by Application
11.1.1.8.4.1 Italy: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.8.5 Italy: Rapid Test Kits Market Breakdown, by End User
11.1.1.9 Spain
11.1.1.9.1 Overview
11.1.1.10 Spain: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.10.1 Spain: Rapid Test Kits Market Breakdown, by Type
11.1.1.10.2 Spain: Rapid Test Kits Market Breakdown, by Product
11.1.1.10.3 Spain: Rapid Test Kits Market Breakdown, by Technology
11.1.1.10.4 Spain: Rapid Test Kits Market Breakdown, by Application
11.1.1.10.4.1 Spain: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.10.5 Spain: Rapid Test Kits Market Breakdown, by End User
11.1.1.11 Rest of Europe
11.1.1.11.1 Overview
11.1.1.12 Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.12.1 Rest of Europe: Rapid Test Kits Market Breakdown, by Type
11.1.1.12.2 Rest of Europe: Rapid Test Kits Market Breakdown, by Product
11.1.1.12.3 Rest of Europe: Rapid Test Kits Market Breakdown, by Technology
11.1.1.12.4 Rest of Europe: Rapid Test Kits Market Breakdown, by Application
11.1.1.12.4.1 Rest of Europe: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.12.5 Rest of Europe: Rapid Test Kits Market Breakdown, by End User
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Rapid Test Kit Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 F. Hoffmann-La Roche Ltd
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Becton Dickinson and Co
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 ARKRAY Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Sysmex Partec GmbH
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Fujirebio Europe NV
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 bioMerieux SA
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Cepheid
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Meril Life Sciences Pvt Ltd
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 QIAGEN NV
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 OraSure Technologies Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Guangzhou Wondfo Biotech Co Ltd
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Denka Co Ltd
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
13.13 Abbott Laboratories
13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Products and Services
13.13.4 Financial Overview
13.13.5 SWOT Analysis
13.13.6 Key Developments
13.14 Trinity Biotech Plc
13.14.1 Key Facts
13.14.2 Business Description
13.14.3 Products and Services
13.14.4 Financial Overview
13.14.5 SWOT Analysis
13.14.6 Key Developments
13.15 Bio-Rad Laboratories Inc
13.15.1 Key Facts
13.15.2 Business Description
13.15.3 Products and Services
13.15.4 Financial Overview
13.15.5 SWOT Analysis
13.15.6 Key Developments
13.16 Hologic Inc
13.16.1 Key Facts
13.16.2 Business Description
13.16.3 Products and Services
13.16.4 Financial Overview
13.16.5 SWOT Analysis
13.16.6 Key Developments
13.17 DiaSorin SpA
13.17.1 Key Facts
13.17.2 Business Description
13.17.3 Products and Services
13.17.4 Financial Overview
13.17.5 SWOT Analysis
13.17.6 Key Developments
13.18 Premier Medical Corp Pvt Ltd
13.18.1 Key Facts
13.18.2 Business Description
13.18.3 Products and Services
13.18.4 Financial Overview
13.18.5 SWOT Analysis
13.18.6 Key Developments
13.19 Beckman Coulter Inc
13.19.1 Key Facts
13.19.2 Business Description
13.19.3 Products and Services
13.19.4 Financial Overview
13.19.5 SWOT Analysis
13.19.6 Key Developments
14. Appendix
14.1 About The Insight Partners
List of Tables
Table 1. Rapid Test Kits Market Segmentation
Table 2. Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 4. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 5. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
Table 6. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 7. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
Table 8. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 9. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 10. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 11. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
Table 12. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 13. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
Table 14. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 15. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 16. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 17. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
Table 18. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 19. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
Table 20. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 21. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 22. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 23. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
Table 24. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 25. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
Table 26. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 27. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 28. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 29. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
Table 30. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 31. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
Table 32. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 33. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 34. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 35. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Technology
Table 36. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 37. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by Infectious Disease Testing
Table 38. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 39. Recent Inorganic Growth Strategies in the Rapid Test Kit Market
Table 40. Recent Organic Growth Strategies in the Rapid Test Kit Market
List of Figures
Figure 1. Rapid Test Kits Market Segmentation, By Country
Figure 2. Rapid Test Kits Market: Key Industry Dynamics
Figure 3. Rapid Test Kits Market: Impact Analysis of Drivers and Restraints
Figure 4. Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Rapid Test Kits Market Share (%) - by Type (2022 and 2030)
Figure 6. Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Rapid Test Kits Market Share (%) - by Product (2022 and 2030)
Figure 10. Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Rapid Test Kits Market Share (%) - by Technology (2022 and 2030)
Figure 13. Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Rapid Test Kits Market Share (%) - by Application (2022 and 2030)
Figure 19. Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Rapid Test Kits Market Share (%) - by End User (2022 and 2030)
Figure 25. Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Europe: Parenteral Nutrition Market, by Key Country - Revenue (2022) (US$ Million)
Figure 30. Europe: Rapid Test Kits Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 31. Germany: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
Figure 32. United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
Figure 33. France: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
Figure 34. Italy: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
Figure 35. Spain: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
Figure 36. Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030(US$ Million)
Figure 37. Growth Strategies in the Rapid Test Kit Market
1. F. Hoffmann-La Roche Ltd
2. Becton Dickinson and Co
3. Sysmex Partec GmbH
4. ARKRAY Inc
5. Fujirebio Europe NV
6. bioMerieux SA
7. Cepheid
8. Meril Life Sciences Pvt Ltd
9. QIAGEN NV
10. OraSure Technologies Inc
11. Guangzhou Wondfo Biotech Co Ltd
12. Denka Co Ltd
13. Abbott Laboratories
14. Trinity Biotech Plc
15. Bio-Rad Laboratories Inc
16. Hologic Inc
17. Premier Medical Corp Pvt Ltd
18. DiaSorin SpA
19. Beckman Coulter Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe rapid test kit market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe rapid test kit market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe rapid test kit market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.